DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

ACTAVIS (NYSE: ACT)

259.75 1.26 (0.49%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ACT $259.75 0.49%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $262.83
Previous Close $258.49
Daily Range $257.02 - $262.83
52-Week Range $156.40 - $270.34
Market Cap $68.8B
P/E Ratio -50.78
Dividend (Yield) $0.00 (0.0%)
Volume 4,512,452
Average Daily Volume 3,501,798
Current FY EPS $13.58

Sector

Healthcare

Industry

Drugs

ACTAVIS (ACT) Description

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products. Website: http://www.actavis.com/

News & Commentary Rss Feed

George Soros Just Bought These 3 Stocks: Should You?

Controversial billionaire George Soros purchased large stakes in AbbVie, Actavis plc, and Valeant Pharmaceuticals in the third-quarter. Should you follow in his footsteps?

Pharma ETFs In Focus On Allergan Takeover Deal

PPG Is Spot-On; The Hazards of Skepticism: Jim Cramer's Best Blogs

November 21 Premarket Briefing: 10 Things You Should Know

Wall Street Breakfast: European Stocks Rise As Draghi Readies QE

Synergy Pharmaceuticals Drug Fares Well in Phase II Study - Analyst Blog

The Crucial Thing You're Missing About Many Dividend Stocks

In this edition of "Where the Money Is," one Motley Fool contributor explains why the earnings payout ratio isn't the ratio dividend investors should actually be watching.

Tracking John Paulson's Paulson & Company Portfolio - Q3 2014 Update

Celgene Up on Encouraging Long-Term Phase III Otezla Data - Analyst Blog

Stock Market News for November 19, 2014 - Market News

See More ACT News...

ACT's Top Competitors

ACT $259.75 (0.49%)
Current stock: ACT
JNJ $107.86 (0.35%)
Current stock: JNJ
NVS $94.98 (-0.30%)
Current stock: NVS
RHHBY $37.33 (-0.93%)
Current stock: RHHBY